相关实验视频

Updated: Sep 15, 2025

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

在妇科癌症中对抗体-药物结合物的临床药理考虑

Victoria M Ettorre¹, Luca Palmieri^1,2, Alessandro D Santin¹

¹Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA.

Expert review of clinical pharmacology

|July 15, 2025

概括

抗体-药物合物 (ADC) 为妇科癌症提供了有前途的新疗法,比传统化疗疗法提高了疗效和耐受性. 需要进一步的研究来确定它们在一线治疗中的作用.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
妇科瘤学妇科瘤学

背景情况:

妇科癌症的传统治疗方法包括手术,化疗,辐射,激素治疗和免疫治疗.
在过去的十年中,抗体药物合物 (ADC) 已经成为一个重大进步,为复发性妇科瘤提供了新的治疗途径.

研究的目的:

审查抗体-药物合物 (ADC) 在妇科恶性瘤治疗中的当前情况和新兴作用.
评估ADC在妇科癌症治疗中的临床活性,耐受性和未来潜力.

主要方法:

在PubMed的文献综述中,使用了与妇科癌症中ADC相关的特定搜索术语.
包括FDA批准的ADC和正在调查中的药物,如tisotumab vedotin,mirvetuximab soravtansine,trastuzumab deruxtecan,sacituzumab govitecan,datopotamab deruxtecan和sacituzumab tirumotecan.这些药物包括在内.

主要成果:

经批准的ADC在妇科癌症中表现出比标准化疗更好的临床活性和更好的耐受性.
ADCs为患有复发性或晚期妇科恶性瘤的患者提供了一种新且有效的治疗选择.

结论:

ADCs是妇科癌症治疗的有前途的新前沿,提供了更好的结果.
广泛采用需要简化病理组织检测.
未来的前性研究是必要的,以确定ADC在一线治疗环境中的最佳作用.

关键词:

在ADC电阻中,ADC的电阻抗体药物结合物抗体药物结合物叶酸受体阿尔法受体是什么妇科癌症妇科癌症在她的2她的2 组织因子是组织因子.这是 trop2 trop2

更多相关视频

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...